Digital Therapeutics (DTx) Market

1. Digital Therapeutics (DTx) Market Trends, Size, Share, Demands, Overview, Growth, Revenue and Forecast to 2030 sales@delvens.comwww.delvens.com

2. Sternal Closure Systems Market – Trends Forecast Till 2030 Digital Therapeutics (DTx) Market, by Product (Software and Devices), Sales Channel (Business-to-Business and Business-to-Consumers), Application (Diabetes, Obesity, Cardiovascular Disease (CVD), Central Nervous System (CNS), Disease Respiratory Disease, Smoking Cessation, Gastrointestinal Disorder (GID) and Others) and region (North America, Europe, Asia-Pacific, Middle East and Africa and South America). Request For Free Sample Report: https://www.delvens.com/get-free-sample/digital-therapeutics-dtx-market sales@delvens.com www.delvens.com

3. Market Overview Digital therapy provides patients with evidence-based therapeutic interventions. It is provided with software and devices designed to manage or treat medical conditions. Digital therapy software can be used alone or in conjunction with another device, medication or treatment to achieve patient treatment and health outcomes. The design, clinical validation, usability and data security of digital therapies are based on state-of-the-art technology according to best practices. These products have been tested and approved by regulatory authorities before use. In addition, digital therapies provide patients, healthcare providers and payers with smart, easy-to-use tools to treat a variety of diseases through interventions such as high-quality, safe and effective evidence-based cards. Purchase this Report: https://www.delvens.com/checkout/digital-therapeutics-dtx-market sales@delvens.com www.delvens.com

4. Market Overview The increase in the use of smartphones and tablets and health applications, the need to control healthcare costs, significant benefits to the entire process of treatment and the increase in the incidence of chronic diseases are driving the growth of the global digital therapy market. The major factors driving the market growth are the increase in the incidence of preventable chronic diseases and the increase in public health funding. Emerging markets also offer companies significant growth opportunities in the coming years. Moreover, strong potential products coming to the market during the forecast period are also beneficial for market participants. Factors such as cost-effectiveness of digital health technologies for providers and patients and increasing need for integrated health systems and patient-centric care are expected to drive market growth during the forecast period. sales@delvens.com www.delvens.com

5. Key Findings The Digital Therapeutics (DTx) market is segmented into various segments such product, sales channel, application and region: The Product segment is further fragmented into Software and Devices. The software segment is the largest and fastest growing segment that dominated the market and is expected to continue this trend during the forecast period due to continuous improvement of firmware and device software’s. The Sales Channel segment is further bifurcated into Business-to-Business and Business-to-Consumers. The business-to-consumers segment is the largest and the fastest growing segment which exhibited the highest growth and is expected to continue this trend during the forecast period. sales@delvens.com www.delvens.com

6. Key Findings The Application segment is further bifurcated into Diabetes, Obesity, Cardiovascular Disease (CVD), Central Nervous System (CNS), Disease Respiratory Disease, Smoking Cessation, Gastrointestinal Disorder (GID) and Others. The market is also divided into various regions such as North America, Europe, Asia-Pacific, South America, and Middle East and Africa. North America is estimated to account for the largest market share during the forecast period. Inquire Before Buying: https://www.delvens.com/Inquire-before-buying/digital-therapeutics-dtx-market sales@delvens.com www.delvens.com

7. Competitive Landscape • Omada Health, Inc. • Welldoc, Inc • Kaia Health • 2MORROW, Inc. • Proteus Digital Health, Inc. • Akili Interactive Labs, Inc. • Pear Therapeutics, Inc. • Resmed, Inc. (Propeller Health) • Fitbit, Inc. (Twine Health, Inc.) • GAIA AG • Limbix Health, Inc. • Click Therapeutics, Inc. • Livongo Health, Inc. • Voluntis, Inc. • Medtronic Plc. • Happify, Inc. • Canary health • Noom, Inc. • HYGIEIA • DarioHealth Corp. • BigHealth sales@delvens.com www.delvens.com

8. Recent Developments In February 2022, DynamiCare Health Inc., a digital therapeutics and telehealth company received Breakthrough Device Designation for DCH-001 from the United States Food and Drug Administration (FDA). In May 2021, Eli Lilly and Company signed strategic international agreements with four companies to advance connected solutions and streamline diabetes care management for individuals living with the disease outside of the United States. sales@delvens.com www.delvens.com

9. Contact Information About Us: Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally. Contact Us: +44-20-3290-6466 +1 214-377-1144 sales@delvens.com sales@delvens.com www.delvens.com